Medical News Today logo Medical News Today 3 weeks ago

ABRAXANE(R) Receives Orphan Drug Status For The Treatment Of Pancreatic Cancer And Stage IIB-IV Melanoma

Main Category: Pancreatic Cancer Also Included In: Melanoma / Skin Cancer Article Date: 08 Nov 2009 - 0:00 PST email to a friend printer friendly view / write opinions rate article Abraxis BioScience, Inc. Full Article at Medical News Today

Related Topics:

  1. Food and Drug Administration
  2. American Cancer Society
  3. US Food and Drug Administration

Related Articles

  1. Medical News Today logo
    BioVex Announces Publication Of Phase 2 Melanoma Results With OncoVEX (GM-CSF) In The Journal Of Clinical Oncology
    3 weeks ago

    Main Category: Melanoma / Skin Cancer Also Included In: Clinical Trials / Drug Trials; Pharma Industry / Biotech Industry Article Date: 03 Nov 2009 - 1:00 PST email to a friend printer friendly view / write opinions rate article BioVex Inc, a... Full Article at Medical News Today

  2. Medical News Today logo
    Data Presented On Oncophage(R) Cancer Vaccine In Recurrent Glioma At SNO 2009
    1 month ago

    Main Category: Cancer / Oncology Also Included In: Clinical Trials / Drug Trials; Immune System / Vaccines Article Date: 28 Oct 2009 - 0:00 PDT email to a friend printer friendly view / write opinions rate article Antigenics (NASDAQ: AGEN)... Full Article at Medical News Today

  3. Medical News Today logo
    BioVex Agrees SPA With The FDA For A Pivotal Phase III Study With OncoVEX (GM-CSF) In Head And Neck Cancer
    2 months ago

    Main Category: Cancer / Oncology Also Included In: Regulatory Affairs / Drug Approvals; Clinical Trials / Drug Trials; Pharma Industry / Biotech Industry Article Date: 16 Sep 2009 - 1:00 PDT email to a friend printer friendly view / write... Full Article at Medical News Today

  4. Medical News Today logo
    FDA And EMEA Grant Orphan Drug Designation For Antisense Pharma's Investigational Drug Trabedersen In Pancreatic Carcinoma
    2 months ago

    Main Category: Pancreatic Cancer Also Included In: Cancer / Oncology; Regulatory Affairs / Drug Approvals Article Date: 15 Sep 2009 - 0:00 PDT email to a friend printer friendly view / write opinions rate article The biopharmaceutical company... Full Article at Medical News Today

Related Quotes

There are no results for this module. Edi the module to change the search term used to query related quotes.

(What's this?)
  1. Are you a Publisher?

    We built Daylife.com using our SmartMedia Services platform, which can give you thousands of content-rich, advertiser-friendly pages (like this one) on any topic and with full editorial control. Learn More »

    Our Customers
    prev
    next
  2. Our Products
    Daylife Select

    A point & click tool to create dynamic content portals. Learn More »

  3. Daylife API

    Unlimited smart, customizable content to suit any publisher. Learn More »

  4. Enterprise API

    Use the Daylife Platform to distribute content across your sites. Learn More »

  5. SmartContext

    Weave the web's best content into your own. Learn More »

Browse More Photos

Daylife is the web's largest archive of news photos

  1. American Cancer Society President Dan Smith, accompanied by Rep. Debbie Wasserman Schultz, D-Fla. , left, and Sen. Amy Klobuchar, D-Minn. , speaks on Capitol Hill in Washington, Wednesday, Oct. 7, 2009, during a news conference, following a hearing on breast cancer legislation by the House Energy...
  2. Assistant Health and Humans Services Secretary for Preparedness and Response Dr. Nicole Lurie, left, accompanied by Food and Drug Administration Acting Chief Scientist Dr. Jesse Goodman, testifies on Capitol Hill in Washington, Wednesday, Nov. 18, 2009, before the joint House Health and Oversight...
  3. SEOUL, SOUTH KOREA - OCTOBER 27: Medical workers of the Korea University Hospital wait for vaccination of H1N1 swine flu vaccine at Korea University Hospital on October 27, 2009 in Seoul, South Korea.
  4. WASHINGTON - SEPTEMBER 29: Senate Judiciary Committee's Crime and Drugs Subcommittee Chairman Arlen Specter (D-PA) delivers an opening statement during a hearing on 'Body Building Products and Hidden Steroids: Enforcement Barriers' on Capitol Hill September 29, 2009 in Washington, DC.

Cast of Characters

  1. Food and Drug Administration Food and Drug Administration
  2. American Cancer Society American Cancer Society
  3. US Food and Drug Administration
  4. Abraxis BioScience, Inc.
  5. U.S. Congress U.S. Congress
  6. CNS, Inc. CNS, Inc.